Last reviewed · How we verify
Ethoxyethane (diethyl ether)
Ethoxyethane (generic name: diethyl ether) is a diethyl ether drug. It is currently in unknown development.
Diethyl ether works by inducing general anesthesia through its effects on the central nervous system.
Ethoxyethane, also known as diethyl ether, is a small molecule drug in the diethyl ether class. It was originally developed, but its current owner is unknown. Diethyl ether is not FDA-approved for any indications, and its commercial status is unclear. As a potent anesthetic and solvent, diethyl ether works by inducing general anesthesia through its effects on the central nervous system. However, due to its potential for abuse and toxicity, its use is largely limited to historical and research contexts.
At a glance
| Generic name | diethyl ether |
|---|---|
| Drug class | diethyl ether |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
When diethyl ether is inhaled or ingested, it quickly enters the bloodstream and crosses the blood-brain barrier, where it binds to receptors in the brain and spinal cord, leading to a loss of consciousness and sensation. This results in a state of general anesthesia, characterized by immobility, amnesia, and a lack of pain perception. Diethyl ether's mechanism of action is complex and not fully understood, but it is thought to involve the modulation of neurotransmitter release and the activation of GABA receptors.
Approved indications
Common side effects
Key clinical trials
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery (PHASE1)
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1,PHASE2)
- Lumbar Fusion With Porous Versus Non-Porous Cages (NA)
- Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease (PHASE1)
- Post-Approval Study Protocol for the Simplify Cervical Artificial Disc (NA)
- Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc
- Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ethoxyethane CI brief — competitive landscape report
- Ethoxyethane updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Ethoxyethane
What is Ethoxyethane?
How does Ethoxyethane work?
What is the generic name of Ethoxyethane?
What drug class is Ethoxyethane in?
What development phase is Ethoxyethane in?
Related
- Drug class: All diethyl ether drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing